SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 445.43-1.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doc Bones who wrote (54)8/9/2001 4:51:19 PM
From: t2  Read Replies (1) of 66
 
Shocker! I read the comments by that division chief in a bloomberg article yesterday and thought this drug was not going to be approved; that it would be DOA.

Last traded at $8.81 and they have over $9 in cash and no debt. Cleanest and simplest balance sheet i have ever seen.

The interesting thing will be what happens with that other drug by that european company.

I had sold over 1/2 of my position in the $11 range after reading the negative comments. I just regret not picking it again at $9 because of the large cash position of the company.

Congrats to all longs.

btw-it was trading in 12 to 13 range two days ago; wonder where it opens tomorrow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext